Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations

Epidermal growth factor receptor (EGFR) is the key molecular target for non-small cell lung cancer (NSCLC) due to its major contribution to complex signaling cascades modulating the survival of cancer cells. Targeting EGFR-mediated signaling pathways has been proved as a potential strategy for NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahalapbutr, Panupong, Wonganan, Piyanuch, Chavasiri, Warinthorn, Rungrotmongkol, Thanyada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521096/
https://www.ncbi.nlm.nih.gov/pubmed/30925736
http://dx.doi.org/10.3390/cancers11040437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521096/
https://www.ncbi.nlm.nih.gov/pubmed/30925736
http://dx.doi.org/10.3390/cancers11040437

Ejemplares similares